SCHEMBL28971352

SCHEMBL28971352

COCC1CC(NC(=O)c2ncc(-c3cccc(C(F)(F)F)c3)o2)CN1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.50
▸ HDAC6 Q9UBN7 6/20 0.50
▸ CYP2C19 P33261 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GRIN1 Q05586 6/20 0.39
▸ GRIN2B Q13224 6/20 0.39
▸ F2R P25116 1/20 0.39
▸ RIPK1 Q13546 1/20 0.39
▸ FAAH O00519 2/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25258088 1.00 HDAC1 (0.50) HDAC1HDAC6CYP2C19CYP1A2GRIN1
SCHEMBL25305510 1.00 HDAC1 (0.50) HDAC1HDAC6CYP2C19CYP1A2GRIN1
SCHEMBL24072831 0.91 HDAC1 (0.47) HDAC1HDAC6CYP2C19CYP1A2GRIN1
SCHEMBL30474057 0.91 HDAC1 (0.47) HDAC1HDAC6CYP2C19CYP1A2GRIN1
SCHEMBL24073669 0.91 HDAC1 (0.47) HDAC1HDAC6CYP2C19CYP1A2GRIN1
SCHEMBL30230922 0.89 HDAC1 (0.43) HDAC1HDAC6RIPK1FAAHPIM1
SCHEMBL30060169 0.89 HDAC1 (0.43) HDAC1HDAC6RIPK1FAAHPIM1
SCHEMBL25258959 0.89 HDAC1 (0.50) HDAC1HDAC6CYP2C19CYP1A2GRIN1
SCHEMBL24073559 0.87 HDAC1 (0.49) HDAC1HDAC6CYP2C19CYP1A2GRIN1
SCHEMBL24072829 0.87 HDAC1 (0.49) HDAC1HDAC6CYP2C19CYP1A2GRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115667252-A N- (1-cyano-pyrrolidin-3-yl) -5- (3- (trifluoromethyl) phenyl) oxazole-2-carboxamide derivatives and corresponding oxadiazole derivatives as USP30 inhibitors for the treatment of mitochondrial dysfunction 特殊治疗有限公司 2023-01-31 — — CN disclosed
Send feedback